24/7
Buzz
Startups
VC
@work
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
DataTech
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Pfizer
Tags search
HOME
24/7
buzz
STARTUPS
VC
Tech@work
Innovation
OPINIONS
EVENTS
ABOUT
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:00
daily.dev raises $11 million in Seed funding to build a professional network for developers
12:15
"Only when women see themselves as decision makers of the future, will their situation change”
10:45
"Investments in Israel have all but disappeared - also because of the judicial coup”
08:20
Israeli startup is aiming to transform how cardiovascular disease is diagnosed and treated
More stories
Buzz
Most popular
Daily
Weekly
1
Check Point tells employees no raises in 2023
2
eToro value plummets, raises $250 million at $3.5 valuation
3
High-tech job market in crisis, isn't expected to rebound soon
4
TripleW raises $16.5 million Series B to produce lactic acid and bioplastic from food waste
5
Israeli startup raises $11 million to use generative AI to help developers test their code
More news
Pfizer
10 stories about Pfizer
Mega-cap tech firms could lag the market next year, but tech in general won't underperform, says UBS chief investment officer
06.12.20
|
Sophie Shulman
Mark Haefele, Chief Investment Officer at UBS Global Wealth Management, says that stock markets will rise and fall depending on how quickly Covid-19 vaccines are approved and distributed
“Excessive regulation” to blame for delay in Israeli Covid-19 vaccine says professor in charge
30.11.20
|
CTech
Director of the Israel Institute for Biological Research says vaccines will be distributed in the summer of 2021
New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist
24.11.20
|
Yafit Ovadia
“There isn’t any need for alarm,” says virologist about new coronavirus vaccines
After a coronavirus vaccine is approved, what happens next?
22.11.20
|
Sophie Shulman
On Dec. 10, the FDA is expected to announce whether it will approve Pfizer’s new vaccine, but 2 trillion people will not receive it until the end of 2021
Markets may recover from pandemic soon, says CapitalG investor
17.11.20
|
CTech
Vaccine announcements, possible removal of U.S. travel ban and other factors will contribute to economic recovery, senior investors say in Calcalist and CTech’s Mind the Tech virtual conference
Moderna’s chief scientist says company initiated vaccine deal with Israel
16.11.20
|
Sophie Shulman
Israeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant
Pfizer and BioNTech claim 90% effective rate for their Covid-19 vaccine
09.11.20
|
Reuters
The news comes at the same time that Israel is currently undergoing human trials of its own vaccine for deployment in 2021
As the Covid-19 vaccine arms race intensifies, big money is at risk
10.08.20
|
Sophie Shulman
Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
Place your bets: Which company will reach a Covid-19 vaccine first?
02.08.20
|
Sophie Shulman
Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason
10.01.19
|
Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
Previous Articles
Please ensure Javascript is enabled for purposes of
website accessibility